GI Dynamics is an exciting and rapidly expanding company in the Boston area. We are focused on developing new therapies for the treatment of Obesity and Diabetes. GI Dynamics is pioneering the approach of noninvasive metabolic control through novel removable devices that modify metabolic pathways. Founded in 2003, GI Dynamics is developing its patented EndoBarrierâ„¢ technology to address the epidemic of metabolic diseases such as obesity and diabetes. GI Dynamics has raised $46 million in three rounds from top-tier venture capital companies including Advanced Technology Ventures, Cutlass Capital, Domain Associates, Johnson & Johnson Development Corporation and Polaris Venture Partners. The company has also assembled a world class group of advisors with specialties in bariatric surgery, gastroenterology, endocrinology and medical weight loss.


Date Type Amount Investors Valuation
07/01/03 Series A 4.1M Domain Associates, Polaris Ventures, Catalyst Health and Technology Partners Unknown
05/01/04 Series B 12M Advanced Technology Ventures, Angel Healthcare Investors, Catalyst Health and Technology Partners, Domain Associates, Polaris Venture Partners, Seedling Enterprises Unknown


Robert Crane (CFO)

Jonathan Hartmann (VP Sales & Marketing)

Sherrie Coval-Goldsmith (Vice President, Regulatory and Clinical Affairs and Quality Assurance)

Jonathan Osgood (Board Member)

Stuart Randle (President/CEO)

View more details about all 11 people at GI Dynamics